SHOT VS CARA Stock Comparison
Performance
SHOT100/100
100/100
SHOT returned 91.94% in the last 12 months. Based on SPY's performance of 13.09%, its performance is above average giving it a score of 100 of 100.
CARA10/100
10/100
CARA returned -89.02% in the last 12 months. Based on SPY's performance of -20.58%, its performance is below average giving it a score of 10 of 100.
Profit
SHOT10/100
10/100
Out of the last 18 quarters, SHOT has had 0 profitable quarters and has increased their profits year over year on 0 of them.
CARA10/100
10/100
Out of the last 20 quarters, CARA has had 1 profitable quarters and has increased their profits year over year on 1 of them.
Volatility
SHOT67/100
67/100
SHOT has had a higher than average amount of volatility over the last 12 months giving it a score of 66 of 100.
CARA41/100
41/100
CARA has had a lower than average amount of volatility over the last 12 months giving it a score of 40 of 100.
Analyst Price Targets
SHOT
"Analyst Price Targets" not found for SHOT
CARA79/100
79/100
7 analysts offer 12-month price targets for CARA. Together, they have an average target of 28, the most optimistic target put CARA at 30 within 12-months and the most pessimistic has CARA at 26.
Sentiment
SHOT
"Sentiment" not found for SHOT
CARA67/100
67/100
CARA had a bullish sentiment score of 67.18% across Twitter and StockTwits over the last 12 months. It had an average of 7.42 posts, 3.60 comments, and 9.03 likes per day.
Technicals
SHOT
"Technicals" not found for SHOT
CARA14/100
14/100
CARA receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.
Earnings
SHOT
"Earnings" not found for SHOT
CARA10/100
10/100
CARA has missed earnings 6 times in the last 20 quarters.
All score calculations are broken down here to help you make more informed investing decisions
Safety Shot, Inc. Common Stock Summary
Nasdaq / SHOT
Healthcare
Drug Manufacturers - Specialty & Generic
Jupiter Wellness, Inc., a wellness company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
Cara Therapeutics, Inc. Summary
Nasdaq / CARA
Healthcare
Biotechnology
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. Its product candidate includes Oral KORSUVA (difelikefalin), which has completed Phase II clinical trial to treat pruritus atopic dermatitis and pruritus non-dialysis-dependent chronic kidney disease (NDD-CKD) associated pruritus; and in Phase II clinical trial to treat pruritus chronic liver disease (CLD) primary biliary cholangitis (PBC) and notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare SHOT to other companies in the same or a similar industry.